ELISA measurement of systemic HMGB1 levels in some other clinical conditions including active systemic lupus erythematosus (SLE) or septic shock has previously been reported to underestimate results reminding of the problems that we encountered in our pilot study in COVID-19 patients. Here, HMGB1 is linked to systemic lupus erythematosus.